These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34623184)

  • 61. Identification of a CTRP9 C-Terminal polypeptide capable of enhancing bone-derived mesenchymal stem cell cardioprotection through promoting angiogenic exosome production.
    Liu D; Gu G; Gan L; Yan W; Zhang Z; Yao P; Zhu D; Lau WB; Xie D; Wu S; Meng Z; Tsukuda J; Christopher T; Lopez B; Zhao J; Gao E; Koch W; Ma XL; Wang Y
    Redox Biol; 2021 May; 41():101929. PubMed ID: 33714738
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MCUb Induction Protects the Heart From Postischemic Remodeling.
    Huo J; Lu S; Kwong JQ; Bround MJ; Grimes KM; Sargent MA; Brown ME; Davis ME; Bers DM; Molkentin JD
    Circ Res; 2020 Jul; 127(3):379-390. PubMed ID: 32299299
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
    Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
    Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N
    Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28726291
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury.
    Chen C; Feng Y; Zou L; Wang L; Chen HH; Cai JY; Xu JM; Sosnovik DE; Chao W
    J Am Heart Assoc; 2014 Jan; 3(1):e000683. PubMed ID: 24390148
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhibiting Fibronectin Attenuates Fibrosis and Improves Cardiac Function in a Model of Heart Failure.
    Valiente-Alandi I; Potter SJ; Salvador AM; Schafer AE; Schips T; Carrillo-Salinas F; Gibson AM; Nieman ML; Perkins C; Sargent MA; Huo J; Lorenz JN; DeFalco T; Molkentin JD; Alcaide P; Blaxall BC
    Circulation; 2018 Sep; 138(12):1236-1252. PubMed ID: 29653926
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activated CD4
    Cai L; Chao G; Li W; Zhu J; Li F; Qi B; Wei Y; Chen S; Zhou G; Lu X; Xu J; Wu X; Fan G; Li J; Liu S
    Aging (Albany NY); 2020 Apr; 12(8):7380-7396. PubMed ID: 32327611
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Conditioned medium from adipose-derived stem cells attenuates ischemia/reperfusion-induced cardiac injury through the microRNA-221/222/PUMA/ETS-1 pathway.
    Lee TL; Lai TC; Lin SR; Lin SW; Chen YC; Pu CM; Lee IT; Tsai JS; Lee CW; Chen YL
    Theranostics; 2021; 11(7):3131-3149. PubMed ID: 33537078
    [No Abstract]   [Full Text] [Related]  

  • 69. M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway.
    Dai Y; Wang S; Chang S; Ren D; Shali S; Li C; Yang H; Huang Z; Ge J
    J Mol Cell Cardiol; 2020 May; 142():65-79. PubMed ID: 32087217
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myocardial infarction-induced microRNA-enriched exosomes contribute to cardiac Nrf2 dysregulation in chronic heart failure.
    Tian C; Gao L; Zimmerman MC; Zucker IH
    Am J Physiol Heart Circ Physiol; 2018 May; 314(5):H928-H939. PubMed ID: 29373037
    [TBL] [Abstract][Full Text] [Related]  

  • 71. BMSC‑derived exosome‑mediated miR‑25‑3p delivery protects against myocardial ischemia/reperfusion injury by constraining M1‑like macrophage polarization.
    Du J; Dong Y; Song J; Shui H; Xiao C; Hu Y; Zhou S; Wang S
    Mol Med Rep; 2024 Aug; 30(2):. PubMed ID: 38904206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction.
    Zhu LP; Tian T; Wang JY; He JN; Chen T; Pan M; Xu L; Zhang HX; Qiu XT; Li CC; Wang KK; Shen H; Zhang GG; Bai YP
    Theranostics; 2018; 8(22):6163-6177. PubMed ID: 30613290
    [TBL] [Abstract][Full Text] [Related]  

  • 73. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
    J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exosomes from adipose-derived mesenchymal stem cells ameliorate cardiac damage after myocardial infarction by activating S1P/SK1/S1PR1 signaling and promoting macrophage M2 polarization.
    Deng S; Zhou X; Ge Z; Song Y; Wang H; Liu X; Zhang D
    Int J Biochem Cell Biol; 2019 Sep; 114():105564. PubMed ID: 31276786
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Apilimod alters TGFβ signaling pathway and prevents cardiac fibrotic remodeling.
    Cinato M; Guitou L; Saidi A; Timotin A; Sperazza E; Duparc T; Zolov SN; Giridharan SSP; Weisman LS; Martinez LO; Roncalli J; Kunduzova O; Tronchere H; Boal F
    Theranostics; 2021; 11(13):6491-6506. PubMed ID: 33995670
    [No Abstract]   [Full Text] [Related]  

  • 76. Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-β receptor 1 signaling pathways.
    Jiang W; Deng B; Xie M; Feng Y; Jiang X; Yang B; Tan Z; Ou H; Tan Y; Liu S; Zhang S; Zhang J; Zhou Y; Wu W; Liu B
    Biomed Pharmacother; 2024 Aug; 177():117012. PubMed ID: 38906025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiac Fibroblast GRK2 Deletion Enhances Contractility and Remodeling Following Ischemia/Reperfusion Injury.
    Woodall MC; Woodall BP; Gao E; Yuan A; Koch WJ
    Circ Res; 2016 Oct; 119(10):1116-1127. PubMed ID: 27601479
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TNF-α antagonism ameliorates myocardial ischemia-reperfusion injury in mice by upregulating adiponectin.
    Gao C; Liu Y; Yu Q; Yang Q; Li B; Sun L; Yan W; Cai X; Gao E; Xiong L; Wang H; Tao L
    Am J Physiol Heart Circ Physiol; 2015 Jun; 308(12):H1583-91. PubMed ID: 25888509
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Matricellular protein CCN1 promotes collagen alignment and scar integrity after myocardial infarction.
    Fischer AG; Elliott EM; Brittian KR; Garrett L; Sadri G; Aebersold J; Singhal RA; Nong Y; Leask A; Jones SP; Moore Iv JB
    Matrix Biol; 2024 Nov; 133():14-32. PubMed ID: 39098433
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression.
    Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC
    J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.